Under 1% of unicorns are profiting at scale with true business success despite $1 billion-plus valuations–Bain & Company analysis

[ad_1] Bain proprietary mapping of the universe of unicorns reveals scarcity of $1 billion start-ups generating matching amounts in revenues and cash generation Just 15 companies, or under 0.7%, of 2,500 unicorns mapped have achieved these measures of successful business insurgency in their markets Founders and investors will need to focus more on real revenues…

Read More

Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

[ad_1] Presented updated data from Phase 1 clinical trial of CT-0508 at CAR-TCR Summit, further supporting CAR-M safety, feasibility and mechanism of action Selected clinical candidate for CT-1119, an anti-mesothelin CAR-Monocyte Presented pre-clinical proof of concept data of in vivo CAR-M, from the Company’s collaboration with Moderna, at SITC Cash, cash equivalents and marketable securities…

Read More